CLAIM #56319 · Thermo Fisher Scientific Inc (TMO) · 2023Q3 earnings call · Oct 25, 2023 · due Dec 31, 2023
“We now assume that they'll contribute approximately $300 million to our reported revenue growth for the year.”
Stephen Williamson · CFO
PENDING
graded after results covering Dec 31, 2023 are reported
How to check this claim
Look at: Contribution to reported revenue growth for the year from the referenced items (acquisitions/COVID-related products, as specified by management)
It came true if: Disclosed contribution approximately $300 million (within +/- $20 million)
Where: Company full-year earnings release / 10-K revenue growth reconciliation and management commentary on Q4/FY2023 call
Verify independently
SEC filings for TMO ↗ · Claim quote is verbatim from the 2023Q3 earnings call.